2023 International Congress » Parkinson's Disease: Cognitive functions

Meeting: 2023 International Congress

10 year longitudinal change in clinical and biological characteristics of sporadic Parkinson Disease PPMI cohort

P. Gonzalez-Latapi, T. Simuni, A. Siderowf, J. Fedler, M. Brumm, C. Gochanour, C. Coffey, K. Marek (Chicago, USA)

Action- and emotion-related language abilities in Slovenian-speaking individuals with Parkinson’s disease – a background normative study

ž. Drakulić Gorše, C. Manouilidou, M. Trošt (Ljubljana, Slovenia)

Addition contact with 10 Hz stimulation in the STN may improve stimulation-induced cognitive disturbances

A. Boogers, M. Cohn, M. Bernstein, A. Fasano (Toronto, Canada)

Adult hippocampal neurogenesis-associated memory performance in people with Parkinson’s disease with and without cognitive impairment

L. Batzu, A. Podlewska, J. Staunton, P. Tall, V. Leta, C. Kim, S. Thuret, K. Ray Chaudhuri (London, United Kingdom)

An analysis of gender differences in the clinical profile of Parkinson’s Disease patients

M. Nasi, N. Cazzola, L. Weis, E. Fiorenzato, V. Cianci, F. Pistonesi, A. Antonini, R. Biundo (Padova, Italy)

Automatic cluster analysis using semantic relatedness for verbal fluency tasks in Parkinson’s disease

T. Hähnel, T. Feige, J. Kunze, A. Epler, A. Frank, J. Bendig, N. Schnalke, M. Wolz, P. Themann, B. Falkenburger (Dresden, Germany)

Can medicinal mushrooms help to stabilize or improve cognitive function in Parkinson’s patients with mild cognitive impairment?

S. Elsas (Arlesheim, Switzerland)

Changes in artistic style and Parkinson’s Disease

AM. Diezma Martín, G. Tabar Comellas, MI. Morales-Casado, DD. Garcia Melendez, JW. Ruiz Gómez, P. Quintana Castro, M. Ennazeh Elkhaili, D. Rivero Rodríguez, N. López Ariztegui (Toledo, Spain)

Changes in word fluency tasks and cognitive function before and after the COVID-19 epidemic in patients with Parkinson’s disease:PD.

M. Sagawa, K. Hasegawa, A. Kumon, M. Saruwatari (Kanagawa, Japan)

Characterization of haemodynamic activity in resting-state networks associated with cognitive decline in PD: a fractal analysis approach

E. Fiorenzato, A. Antonini, L. Weis, R. Biundo, V. D’Onofrio, F. Ferreri, S. Moaveninejad, C. Porcaro (Padova, Italy)

Clinical toolkits to improve conversations about Parkinson’s dementia

I. Dobreva, J. Thomas, M. Roche, C. Dore, S. Rose, S. Baldwin-Jones, R. O'Connell, A. Marr, C. Hugill, R. Weil (London, United Kingdom)

Cognitive overlap between Parkinson disease (PD) and Alzheimer’s disease (AD) is associated with plasma biomarkers and their impact on regional cortical thickness (CT): An ONDRI Study

M. Masellis, G. Coughlan, P. Zhukovsky, E. Sanchez, D. Munoz, R. Buckley, T. Steeves, P. Mclaughlin, D. Grimes, M. Jog, C. Marras, H. Zetterberg, H. Kvartsberg, M. Binns, SE. Black, AE. Lang (Toronto, Canada)

Cognitive underside of Parkinson’s Disease: A working memory updating failure in freezing of gait

M. Mandal, A. Khan (PUNE, India)

Comparison in the disability level according to WHODAS 2 between people living with Early and Late Onset Parkinson’s Disease

M E. Pimentel Piemonte, K. Costa Nobrega, I. Silva Nascimento, B. Antunes Souza, I. Carneiro Barone, G. Checchio, V. Pereira Ponciano, C. Cerveira Paula, A. Nunes Possani, N. Cardos Penha (Sao Paulo, Brazil)

Comparison of cognitive , affective and autonomic functions in parkinson’s disease patients with and without freezing of gait and its correlation with PET/CT

K. Harisankar, S. Mehta, R. Kumar, M. Mohanty, S. Singh, N. Balaini, V. Lal (CHANDIGARH, India)

Computerized cognitive training in advanced Parkinson’s disease: preliminary feasibility data of an ongoing randomized controlled trial

P. Olgemöller, E. Kalbe, C. Hennen, M. Barbe, M. Hellmich, AK. Folkerts (Cologne, Germany)

Correlation between rem sleep disorders and neurocognitive defects in patients with parkinson´s disease

M. Castillo, A. Mariñez, J. Duran, I. Joga, A. Morales (santo domingo, Dominican Republic)

Differences by sex in patients with Parkinson’s disease (PD) and impulse control disorder (ICD) in the Mexican population.

A. Alcocer-Salas, M. Rodriguez-Violante, A. Cervantes-Arriaga, J. García-Hernández, A. Abundes-Corona, A. Hernández-Medrano, D. Aguila-Godinez, A. Herrera-Ruiz, E. Santiago-Delacruz, L. Lira-Juárez, M. Medrano-Delgado, M. Ruiz-Mafud, A. Regalado-Mustafá, D. Romero-Terán, M. Medina-Pérez, G. Hernandez-Armesto, A. Domínguez-García (Merida, Mexico)

Disease progression in Parkinson‘s disease patients with Mild Cognitive Impairment: 5-year longitudinal study from The Early Parkinson’s disease Longitudinal Singapore (PALS) cohort

X. Deng, S. Saffari, S. Ng, N. Chia, X. Choi, D. Heng, B. Xiao, Z. Xu, K. Tay, W. Au, N. Liu, E. Tan, L. Tan (Singapore, Singapore)

Does Cognitive Complaint in Parkinson’s Disease Reflect in Neuropsychological Testing?

C. Catiul, S. Lopez, V. Mishra (Birmingham, USA)

Does sex affect worsening of cognitive and IADL functions in PD with and without PD-MCI?

I. Liepelt-Scarfone, M. Bode, S. Solbrig, K. Brockmann, W. Maetzler, I. Wurster, M. Timmers, D. Berg, S. Becker (Tübingen, Germany)

Does sleep disorder affect cognitive impairment in Parkinson’s disease?

M. Miyashita, K. Hasegawa, M. Sagawa, A. Kumon (kanagawa, Japan)

Early cognitive decline in Parkinson’s disease is anticipated by enhanced frontal theta oscillations and minor hallucinations

F. Bernasconi, J. Pagonabarraga, H. Bejr-Kasem, S. Martinez-Horta, J. Marín-Lahoz, A. Horta-Barba, J. Kulisevsky, O. Blanke (Geneva, Switzerland)

Effect of levodopa on the interpretation of social interactions in people living with Parkinson’s disease

T. Danaila, E. Metereau (Bron, France)

Effects of a rhythmic auditory stimulation-enhanced walking program on Veterans with Parkinson’s disease with and without subthalamic nucleus deep brain stimulation.

A. Umbarger, S. Kletzel, S. Walker, C. Jelinek, C. Kestner, K. Krese, B. Mcreavy, T. Bender Pape, F. Weaver, K. Colletta (Gary, USA)

Effects of cerebellar theta burst stimulation on working memory in Parkinson’s disease

N. Raies, J-F. Nankoo, T. Grippe, R. Chen (Toronto, Canada)

Evaluation of Cognitive Assessment Tools in Parkinson’s Disease

L. Cao, Y. Huang (Beijing, China)

Excessive daytime sleepiness as a predictor of cognitive decline in Parkinson disease

N. Deturk, W. Dalrymple (Charlottesville, USA)

Failure of model-based outcome monitoring in Parkinson’s Disease Apathy

W. Gilmour, G. Mackenzie, M. Feile, A. Macleod, V. Marshall, D. Steele, T. Gilbertson (Dundee, United Kingdom)

Impact of non-pharmacological strategies on progression in Parkinson’s Disease and Cognitive Impairment.

MAG. Medrano-Delgado, DR. Aguila-Godinez, MF. Ruiz-Mafud, LG. Lira-Juárez, EC. Santiago Delacruz, A. Domínguez-García, AJ. Hernández-Medrano, AY. Regalado-Mustafá, MF. Medina-Pérez, G. Hernandez-Armesto, K. Talavera-Laguna, A. Herrera-Ruiz, J. García-Hernández, DP. Romero-Terán, A. Alcocer-Salas, G. Cerda-Hernández, A. Abundes-Corona, M. Rodríguez-Violante, A. Cervantes-Arriaga (Ciudad de Mexico, Mexico)

Influence of Cognitive Function on Obstacle-Crossing Performance in People with Parkinson’s Disease: A Cross-Sectional Study

HH. Hsu, RY. Wang, NC. Yeh, PL. Wong, CW. Hung (Taipei, Taiwan)

Is an integrated Parkinson’s Dementia Service the way forward?

A. Rafeeq, C. Thomas, B. Mohamed, J. Adenwalla, S. Page, R. Lewis-Morton, S. Mahon, T. Williams (Cardiff, United Kingdom)

Leveraging MRI and machine-learning for early detection of cognitive impairment in Parkinson’s disease

L. Saadatpour, A. Vijayakumari, B. Walter, H. Fernandez (Cleveland, USA)

local field potential differences in stn subregion during performance of a conflict task in humans with parkinson’s disease

J. Bowersock, J. Neimat, A. Alhourani, T. Stewart, S. Wylie, N. van Wouwe (Flagstaff, USA)

London-Dhaka Parkinson’s Cognition Study: A collaboration to evaluate cognitive impairment in under-represented Parkinson’s disease patients

T. Zannat, K. Dey, A. Zirra, A. Haque, E. Camboe, T. Haque, S. Waters, D. Mair, C. Marshall, A. Noyce, A. Habib (Dhaka, Bangladesh)

Long-term dementia prevalence in Parkinson disease: Glass half-full?

J. Gallagher, J. Fedler, C. Gochanour, R. Dobkin, D. Aarsland, R. Alcalay, M. Barrett, C. Caspell-Garcia, R. Cho, L. Chahine, A. Chen-Plotkin, C. Coffey, N. Dahodwala, J. Eberling, A. Espay, J. Leverenz, I. Litvan, E. Mamikonyan, J. Morley, I. Richard, L. Rosenthal, A. Siderowf, T. Simuni, M. York, A. Willis, S. Xie, D. Weintraub (Philadelphia, USA)

Motor subtype stability and cognitive profiles in early Parkinson’s disease

N. Chia, S. Ng, X. Choi, D. Heng, S. Neo, Z. Xu, K. Tay, W. Au, E. Tan, L. Tan (Singapore, Singapore)

Muscle functions on the movement timings and inhibition in Parkinson’s disease.

H. Singh, K S. Anand (Mysore, India)

Musical Perception in Parkinson’s Disease, a Pilot Study

K. Vourou (Athens, Greece)

No laughing white matter: reduced integrity of the lateral nucleus basalis of Meynert pathway in Parkinson’s disease-related cognitive impairment

R. Crockett, K. Wilkins, S. Aditham, H. Bronte-Stewart (Stanford, USA)

Orthostatic hypotension exacerbates gray matter atrophy related to REM sleep behavior disorder in de novo Parkinson’s disease

T. Shiraishi, T. Umehara, Y. Iguchi (Tokyo, Japan)

Parkinson disease patient’s awareness of hyperkinetic movements

W. Chouhani, S. Barua, L. Elansari, T. Hatfield, R. Buesa, J. Friedman, U. Akbar (Fez, Morocco)

PD-PROP reporting in participants own words shows high burden of cognitive symptoms in early Parkinson Disease (PD)

J. Purks, L. Arbatti, A. Hosamath, A. Amara, K. Anderson, L. Chahine, S. Eberly, D. Kinel, S. Mantri, S. Mathur, D. Oakes, D. Standaert, D. Weintraub, I. Shoulson, C. Marras (Rochester, USA)

Piloting the Cats-and-Dogs tool as a culture-fair test for sensory processing impairment in Parkinson’s disease

D. Mair, K. Dey, E. Camboe, A. Zirra, R. Weil, D. Gallagher, C. Budu, T. Haque, A. Noyce, C. Marshall, S. Waters (London, United Kingdom)

Prediction of postoperative delirium after deep brain stimulation surgery in Parkinson`s disease

M. Astalosch, M. Mousavi, L. Martins Ribeiro, GH. Schneider, H. Stuke, S. Haufe, F. Borchers, C. Spies, J. von Hofen-Hohloch, B. Al-Fatly, G. Ebersbach, C. Franke, A. Kühn, D. Kübler-Weller (Berlin, Germany)

Prevalence of cardiovascular drugs and oral anticoagulants use among persons with and without Parkinson’s disease

B. Babar (Kuopio, Finland)

Prodromal dementia with Lewy bodies in REM sleep behavior disorder: A multicenter study

S. Joza, M. Hu, KY. Jung, D. Kunz, D. Arnaldi, JY. Lee, L. Ferini-Strambi, E. Antelmi, F. Sixel-Döring, V. de Cock, J. Montplaisir, M. Lawton, HJ. Kim, F. Bes, P. Mattioli, K. Woo, S. Marelli, G. Plazzi, B. Mollenhauer, A. Pelletier, JS. Sunwoo, N. Girtler, C. Trenkwalder, JF. Gagnon, R. Postuma (Montreal, Canada)

Protective effect and mechanism of TREM2 in Parkinson’s disease with cognitive impairment

P. Zhang, Y. Zhang (Guanzhou, China)

Reduced non-REM sleep in Parkinson disease is associated with memory impairment and non-motor symptom burden

S. Shah, C. Dintino, S. Lageman, N. Mukhopadhyay, E. Shelton, S. Holden, J. Broussard, L. Cloud, M. Barrett, B. Berman (Richmond, USA)

Strategic decision-making in Parkinson’s disease with fatigue

C. Pauletti, D. Mannarelli, F. Milano, A. Maffucci, A. Petritis, F. Fattapposta (Rome, Italy)

Subjective cognitive decline as predictor of objective cognitive decline in Parkinson’s patients

T. Blum, H. Wurp, S. Wolfsgruber, M. Wagner, L. Consortium, R. Dodel (Essen, Germany)

The crucial role of the visual system on the PISA syndrome in Parkinson’s disease

A. Yoritaka, T. Hayashi, K. Fusegi, S. Nakayama, M. Ando, N. Hattori (Koshigaya, Saitama, Japan)

The East London Parkinson Disease Project – preliminary results from a diverse population

A. Zirra, KC. Dey, E. Camboe, T. Haque, A. Ben-Joseph, J. Kahan, D. Gallagher, C. Budu, B. Huxford, C. Simonet, A. Lees, CR. Marshall, AJ. Noyce (London, United Kingdom)

The effect of subthalamic deep brain stimulation on response inhibition and voluntary action control depend on connectivity of the volume of activated tissue with the prefrontal cortex

J. Waldthaler, A. Sperlich, C. Stüssel, K. Steidel, L. Timmermann, D. Pedrosa (Marburg, Germany)

The investigation of a novel video game for identifying mild cognitive impairment in individuals with Parkinson’s disease

K. Carey, G. Postma, B. Trokthi, C. Maitland (Corinth, USA)

The Parkinson’s Disease Composite of Executive-Functioning (PaCEF): A measure for detecting cognitive decline for Parkinson’s disease clinical trials

C. Young, B. Cholerton, M. Shahid, C. Abdelnour, C. Zabetian, T. Montine, K. Poston (Stanford, USA)

Understanding the Mechanisms of Brain Dysfunction when Performing the Mental Rotation Task (MRT) in Stage 1 and Stage 2 EOPD using brain imaging

J. Razzaque, B. Mullen, C. Dougherty, A. Cotton, D. Wagner, S. Ravi, K. Le, K. Iyer, M. Subramanian, J. Wang, K. Venkiteswaran, T. Subramanian, P. Eslinger (Toledo, USA)